In humans, sfpq mutations have been linked to neurodegenerative diseases such as Alzheimer’s, ALS, and FTD, and SFPQ interacts with the ALS-associated RNA-binding proteins TDP-43 and FUS28–33. Here, SFPQ is linked to amyotrophic lateral sclerosis.